BMY

Bristol Myers Squibb Co
74.705
0.255 (0.34%)

Bristol-Myers Squibb Company (BMY) Fundamentals

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
SHARE INFORMATION
Market Cap$ 158,292,637,834
Shares Outstanding2,126,160,347
Float2,124,706,403
Percent Float99.93%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 2.19
Latest Fiscal Revenue$ 46,159,000,000
Latest Fiscal EPS$ 2.95
Latest Fiscal Date2022-12-31
DIVIDENDS
Dividend (3 Years)$ 6.94
Dividend (5 Years)$ 7.62
Ex Dividend Date2023-01-05
Dividend Rate$ 2.28
Dividend Yield3.06%
Payment CashCash
HOLDERS
Institutions4,000
Institutional Holdings Date2023-01-31
Institutional Bought Previous 3 Months81,931,387
Institutional Holdings Percent137.3%
Institutional Sold Previous 3 Months173,801,344
Insider Holdings Date2023-01-31
Insider Bought Previous 3 Months76,138
Insider Holdings Percent0.3
Insider Sold Previous 3 Months145,330
Insider Shares Owned6,287,635
TRADING INFO
52 Week High$ 81.44
52 Week Low$ 62.90
52 Week High Change$ 19.71
21 Day Moving Average$ 72.5391
21 Day Extended Moving Average$ 72.9315
50 Day Moving Average$ 74.4826
50 Day Extended Moving Average$ 73.7419
200 Day Moving Average$ 73.375
200 Day Extended Moving Average$ 73.0281
10 Day Average Volume8,550,882
20 Day Average Volume8,640,563
30 Day Average Volume8,141,466
50 Day Average Volume8,706,594
Alpha0.003969
Beta0.4325
Standard Deviation0.066189
R20.124580
7 Day Price Change$ 2.00
7 Day Percent Change2.76%
21 Day Price Change$ 1.94
21 Day Percent Change2.68%
30 Day Price Change$ 2.76
30 Day Percent Change3.85%
Month to Date Price Change$ 1.80
Month to Date Percent Change2.48%
Quarter to Date Price Change$ 3.06
Quarter to Date Percent Change4.29%
180 Day Price Change$ 2.58
180 Day Percent Change3.59%
200 Day Price Change$ 1.84
200 Day Percent Change2.54%
Year to Date Price Change$ 3.06
Year to Date Percent Change4.29%

Bristol-Myers Squibb Company (BMY) Key Ratios

PROFITABILITY
EBIT Margin19.2%
EBITDA Margin41.3%
Pre-Tax Profit Margin-3.3%
Profit Margin Count13.75%
Gross Margin78.0%
Profit Margin TOT13.75%
INCOME STATEMENTS
Revenue$ 46,159,000,000
Revenue Per Share$ 21.71
Revenue (3 Years)$ 19.63
Revenue (5 Years)$ 20.89
FINANCIAL STRENGTH
Price to Tangible Book-5.70
Total Debt To Equity1.20
Int Coverage7.30
Current Ratio1.40
Leverage Ratio3.10
Quick Ratio1.20
Long Term Debt To Capital0.54
VALUATION MEASURES
PE Ratio25.20
Enterprise Value$ 189,375,637,834
Price to Sales3.4293
Price to Free Cash73.80
PE High Last 5 Years116.80
Price To Book4.60
Price To Cash Flow11.60
PE Low Last 5 Years-13.30
Price to Tangible Book-5.70
MANAGEMENT EFFECTIVENESS
Receivables Turnover2.10
Invoice Turnover9.70
Assets Turnover0.20
Return Assets5.79
Return on Equity17.60
Return on Capital9.97

Bristol-Myers Squibb Company (BMY) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorDeloitte & Touche LLP
CEOGiovanni Caforio
Emplyoees32200
Last AuditUQ
CIK0000014272
IndustryDrug Manufacturers
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address430 East 29th Street
14th Floor
New York, NY 10016
Websitehttps://www.bms.com
Facsimile-
Telephone+1 212 546-4000
Emailtimothy.power@bms.com


Your Recent History
NYSE
BMY
Bristol My..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.